Doximity (DOCS) closed at $41.36, down 5.7% from the previous session, underperforming the S&P 500. Analysts expect an EPS of $0.44, a 2.22% decrease from last year. Revenue is projected to be $181.03 million, a 7.37% increase. Doximity has a Zacks Rank of #2 (Buy) with positive estimate revisions.

Valuation-wise, Doximity has a Forward P/E ratio of 28.04, lower than the industry average of 29.42. The PEG ratio is 1.48, below the industry average of 2.33. The Medical Info Systems industry, where Doximity belongs, has a Zacks Industry Rank of 160, in the bottom 35% of all industries.

Zacks’ Research Chief names a little-known satellite-based communications firm as the top stock set to potentially double in value. With a growing customer base and potential revenue breakout in 2025, this stock is projected to outperform. Check out the 5 stocks with the greatest probability of +100% gains in the coming months.

Read more at Nasdaq: Doximity (DOCS) Declines More Than Market: Some Information for Investors